$Allakos(ALLK.US)$Allakos | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.8%) SEC announcement · 01/29 17:30
1
1
举报
JCBF楼主 :
Allakos | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.R.S. IDENTIFICATION NO. John P. McKearn, Ph.D.(0.2%),I.R.S. IDENTIFICATION NO. Thomas C. Melzer(0.03%)
$Allakos(ALLK.US)$Allakos Announced Topline Data From Its Phase 2 Trial For Lirentelimab In Atopic Dermatitis (ATLAS) And Phase 2B Study In Chronic Spontaneous Urticaria (MAVERICK); The Studies Did Not Meet Their Primary Endpoints